177 related articles for article (PubMed ID: 24792491)
1. FRK suppresses the proliferation of human glioma cells by inhibiting cyclin D1 nuclear accumulation.
Hua L; Zhu M; Song X; Wang J; Fang Z; Zhang C; Shi Q; Zhan W; Wang L; Meng Q; Zhou X; Yu R
J Neurooncol; 2014 Aug; 119(1):49-58. PubMed ID: 24792491
[TBL] [Abstract][Full Text] [Related]
2. Activation of STAT1 by the FRK tyrosine kinase is associated with human glioma growth.
Hua L; Wang G; Wang Z; Fu J; Fang Z; Zhuang T; Zhao L; Zong Z; Ye C; Liu H; Zhu Y; Yu R
J Neurooncol; 2019 May; 143(1):35-47. PubMed ID: 30993511
[TBL] [Abstract][Full Text] [Related]
3. FRK suppresses human glioma growth by inhibiting ITGB1/FAK signaling.
Wang J; Cai C; Nie D; Song X; Sun G; Zhi T; Li B; Qi J; Zhang J; Chen H; Shi Q; Yu R
Biochem Biophys Res Commun; 2019 Oct; 517(4):588-595. PubMed ID: 31395336
[TBL] [Abstract][Full Text] [Related]
4. FRK controls migration and invasion of human glioma cells by regulating JNK/c-Jun signaling.
Zhou X; Hua L; Zhang W; Zhu M; Shi Q; Li F; Zhang L; Song C; Yu R
J Neurooncol; 2012 Oct; 110(1):9-19. PubMed ID: 22790444
[TBL] [Abstract][Full Text] [Related]
5. FRK inhibits migration and invasion of human glioma cells by promoting N-cadherin/β-catenin complex formation.
Shi Q; Song X; Wang J; Gu J; Zhang W; Hu J; Zhou X; Yu R
J Mol Neurosci; 2015 Jan; 55(1):32-41. PubMed ID: 24969324
[TBL] [Abstract][Full Text] [Related]
6. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology.
Goel RK; Lukong KE
Cancer Metastasis Rev; 2016 Jun; 35(2):179-99. PubMed ID: 27067725
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-519d-3p inhibits cell proliferation and cell cycle G1/S transition in glioma by targeting CCND1.
Ma L; Li J
Biosci Biotechnol Biochem; 2020 Feb; 84(2):297-304. PubMed ID: 31661371
[TBL] [Abstract][Full Text] [Related]
8. The Rak/Frk tyrosine kinase associates with and internalizes the epidermal growth factor receptor.
Jin L; Craven RJ
Oncogene; 2014 Jan; 33(3):326-35. PubMed ID: 23318459
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrest.
Gao J; Zhang JY; Li YH; Ren F
Int J Clin Exp Pathol; 2015; 8(9):10130-8. PubMed ID: 26617720
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cell cycle progression by penta-acetyl geniposide in rat C6 glioma cells.
Chang YC; Chou FP; Huang HP; Hsu JD; Wang CJ
Toxicol Appl Pharmacol; 2004 Jul; 198(1):11-20. PubMed ID: 15207644
[TBL] [Abstract][Full Text] [Related]
11. BRG1 expression is increased in human glioma and controls glioma cell proliferation, migration and invasion in vitro.
Bai J; Mei PJ; Liu H; Li C; Li W; Wu YP; Yu ZQ; Zheng JN
J Cancer Res Clin Oncol; 2012 Jun; 138(6):991-8. PubMed ID: 22362300
[TBL] [Abstract][Full Text] [Related]
12. Annexin A2 regulates glioma cell proliferation through the STAT3‑cyclin D1 pathway.
Chen L; Lin L; Xian N; Zheng Z
Oncol Rep; 2019 Jul; 42(1):399-413. PubMed ID: 31115554
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1.
Hui W; Yuntao L; Lun L; WenSheng L; ChaoFeng L; HaiYong H; Yueyang B
PLoS One; 2013; 8(1):e54932. PubMed ID: 23383003
[TBL] [Abstract][Full Text] [Related]
14. Progesterone inhibits the estrogen-induced phosphoinositide 3-kinase-->AKT-->GSK-3beta-->cyclin D1-->pRB pathway to block uterine epithelial cell proliferation.
Chen B; Pan H; Zhu L; Deng Y; Pollard JW
Mol Endocrinol; 2005 Aug; 19(8):1978-90. PubMed ID: 15845746
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.
Coupland SE; Bechrakis N; Schüler A; Anagnostopoulos I; Hummel M; Bornfeld N; Stein H
Br J Ophthalmol; 1998 Aug; 82(8):961-70. PubMed ID: 9828785
[TBL] [Abstract][Full Text] [Related]
16. The role of transcriptional coactivator TAZ in gliomas.
Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
[TBL] [Abstract][Full Text] [Related]
17. FRK inhibits glioblastoma progression via phosphorylating YAP and inducing its ubiquitylation and degradation by Siah1.
Wang Y; Wang K; Fu J; Zhang Y; Mao Y; Wang X; Wang X; Yu R; Zhou X
Neuro Oncol; 2022 Dec; 24(12):2107-2120. PubMed ID: 35723276
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation.
Sanmartín-Salinas P; Lobo MDVT; Noguerales-Fraguas F; Londoño MT; Jiménez-Ruiz A; Guijarro LG
J Gastroenterol; 2018 Aug; 53(8):932-944. PubMed ID: 29353348
[TBL] [Abstract][Full Text] [Related]
19. Down-Regulation of miR-2053 Inhibits the Development and Progression of Esophageal Carcinoma by Targeting Fyn-Related Kinase (FRK).
Wang B; Zhang L; Li J; Hua P; Zhang Y
Dig Dis Sci; 2020 Oct; 65(10):2853-2862. PubMed ID: 31894485
[TBL] [Abstract][Full Text] [Related]
20. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
